Abstract:BackgroundUrinary tract infections (UTIs) are among the most common infectious diseases in humans and represent a critical health problem, especially due to a significant rise in global antibiotic use in recent years. The purpose of this study was to describe the main uropathogens and determine the antimicrobial resistance profiles among inpatients at public hospitals in the largest city in Brazil, comparing three different epidemiological periods: pre-Covid-19 (2018-2019), Covid-19 (2020-2021) and post-Covid-19 (2022-2023).MethodsA 6-year retrospective review of laboratory data from 12 public hospitals of São Paulo city from January 2018 to December 2023. The urine samples were cultivated onto ChromID ® CPS agar plates and then incubated at 35°C for 18-24 h. The bacteria identification was performed by MALDI-TOF mass spectrometry (Vitek-MS), and the minimal inhibitory concentrations of antibiotics were determined using the Vitek ® 2 system. Only positive results with one bacterial species and a colony count ≥ 10 5 CFU/mL was considered for descriptive analysis.ResultsIn the 6-year period, a total of 58,738 microorganisms from hospitalized patients were included. The frequency of isolates detected during the period were: 33.9% (19,338/58,738) in pre-Covid-19, 30.1% (17,688/58,738) in Covid-19 and 36.9% (21,712/58,738) in post-Covid-19 period. The top ten microorganisms' prevalence detected in pre-Covid-19, Covid-19 and post-Covid-19 periods were as follow: 23,951 Escherichia coli (47.5%; 37.1%; 37.7%), 9,247 Klebsiella pneumoniae (12.5%; 14.3%; 19.8%), 7,640 Candida spp. (8.8%; 19.2%; 11.7%), 5,476 Enterococcus spp. (8%; 10%; 9.9%), 3,101 Proteus mirabilis (5.56%; 4.9%; 5.4%), 2,166 Pseudomonas aeruginosa (3.3%; 3.5%; 4.1%), 1,252 Coagulase-Negative Staphylococcus (CoNS) (2.5%; 1.6%; 2.2%), 1,166 Enterobacter spp. (2.3%; 2.1%; 1.6%), 1,088 Streptococcus spp. (3.6%; 1.2%; 0.8%) and 758 Acinetobacte r spp. (0.8%; 1.5%; 1.5%). Extended spectrum beta-lactamase rates for E. coli were 16.8% and 20.2% and for K. pneumoniae were 65.7% and 65.2% in Covid-19 and Post-Covid-19 periods, respectively. The resistance to carbapenems was observed mainly in Acinetobacter spp. (85.7%, 93.8% and 80.7%), K. pneumoniae (38.3%, 42.6% and 47.3%), Pseudomonas aeruginosa (22.3%, 23.1% and 25%), and Proteus spp. (0.2%, 1.9% and 5%). Between the Gram-positive cocci, the resistance to vancomycin was observed mainly in E. faecium (43.5%, 37.5%, 30.2%) and the resistance to methicillin was detected in S. aureus (30.1%, 35.8%, 34.1%) and CoNS (31.9%, 47.8%, 53.5%).ConclusionsIn this study, we observed an increase in the incidence of Candida spp. coinciding with the start of the pandemic period. Overall, the frequency of uropathogens isolated from hospital centers increased and exhibited high resistance to various classes of antimicrobial agents. ESBL-producing K. pneumoniae and Carbapenem-resistant Enterobacteriacea , and nonfermenters such as Acinetobacter spp. and P. aeruginosa constitute serious problems in Brazilian hospitals.

Prevalence and molecular characterization of carbapenem-resistant Enterobacterales in patients from a public referral hospital in a non-metropolitan region of Brazil during and post the SARS-CoV-2 pandemic

A 7-Year Brazilian National Perspective on Plasmid-Mediated Carbapenem Resistance in Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii Complex and the Impact of the Coronavirus Disease 2019 Pandemic on Their Occurrence

Genetic profile and characterization of antimicrobial resistance in Acinetobacter baumannii post-COVID-19 pandemic: a study in a tertiary hospital in Recife, Brazil

National Multicenter Study on the Prevalence of Carbapenemase-Producing Enterobacteriaceae in the Post-COVID-19 Era in Argentina: The RECAPT-AR Study

First Report of Coexistence of blaKPC-2 and blaNDM-1 in Carbapenem-Resistant Clinical Isolates of Klebsiella aerogenes in Brazil

Carbapenem-resistant Enterobacteriaceae in patients admitted to the emergency department: prevalence, risk factors, and acquisition rate

Genomic analysis and antimicrobial activity of β-lactam/β-lactamase inhibitors and other agents against KPC-producing Klebsiella pneumoniae clinical isolates from Brazilian hospitals

Hospital sewage in Brazil: a reservoir of multidrug-resistant carbapenemase-producing Enterobacteriaceae

Long-term occurrence of multiple antimicrobial drug resistant Klebsiella pneumoniae isolates harboring virulent potential in a tertiary hospital from Brazil

Biodiversity of carbapenem-resistant bacteria in clinical samples from the Southwest Amazon region (Rondônia/Brazil)

Virulent Klebsiella pneumoniae ST11 clone carrying bla KPC and bla NDM from patients with and without COVID-19 in Brazil

Epidemiological and molecular study of Providencia rettgeri outbreak at a university hospital during the COVID-19 reference center

A-288 Active Surveillance Cultures: Frequency of Microorganisms and Phenotypic Resistance Profile From Brazilian Public Hospitals After COVID-19 Pandemic Peak

A retrospective study on molecular epidemiology trends of carbapenem resistant Enterobacteriaceae in a teaching hospital in Malaysia

A-255 Microbiological Profile and Frequency Distribution of Uropathogens in Brazilian Public Hospitals. Data From a Clinical Laboratory (2018-2023)

Persistent carbapenem resistance in mechanically ventilated ICU patients: A before-and-after analysis of the COVID-19 surge

Epidemiological and clinical characteristics of patients with carbapenem-resistant Enterobacterales in a university hospital of Colombia: Enzyme coproductions in rise

Genomic Insights into the expansion of Carbapenem-Resistant Klebsiella pneumoniae within Portuguese Hospitals

High Prevalence of Multidrug-Resistant Klebsiella pneumoniae Harboring Several Virulence and β-Lactamase Encoding Genes in a Brazilian Intensive Care Unit

Emerging threat: Antimicrobial resistance proliferation during epidemics — A case study of the SARS-CoV-2 pandemic in South Brazil

Molecular characterization and descriptive analysis of carbapenemase-producing Gram-negative rod infections in Bogota, Colombia